Blog Posts

Vincent Rajkumar: Reflecting on Top Cited IMWG Papers and the Legacy of Velcade in Myeloma

Vincent Rajkumar/X

Jun 8, 2025, 22:44

Vincent Rajkumar: Reflecting on Top Cited IMWG Papers and the Legacy of Velcade in Myeloma

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic, posted on X:

“As I head to the 16th Annual IMWG summit, I see that 2 of my Top 3 most cited papers are IMWG work. Thanks to my wonderful colleagues. 3 is the SUMMIT trial that led to the first approval of Velcade for myeloma 22 years ago.”

Vincent Rajkumar

16th Annual IMWG summit cancer Myeloma OncoDaily Oncology Vincent Rajkumar

Vinay Prasad Rejoins FDA Days After Exit

New Paper Alert: Safety and Outcomes of T-DXd Retreatment After Grade 1 ILD Recovery

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Tyler Seibert: 10-year Results of FLAME Trial is Out Now

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Blog Posts

Aug 15, 2025, 08:03

Carmen Monge-Montero: Sometimes the Bravest Thing You Can Do is Ask for Help

Science

Aug 15, 2025, 07:31

Bishoy Morris Faltas: Paired Plus-Minus Sequencing for Accurate Dual-Strand DNA Analysis

Stories

Aug 15, 2025, 06:47

Oya Gilbert's Story Highlights Urgent Need to Protect NIH Research Funding - AACR

Science

Aug 15, 2025, 06:42

Denis Panizza: How Tight Can SBRT Prostate Margins Go?

Science

Aug 15, 2025, 06:33

Immune Youth in Old Age: Mayo Clinic Uncovers the Double-Edged Sword - E. Shyam P. Reddy

Voices

Aug 15, 2025, 06:32

Where AI Meets the Future of Cancer Research - NFCR

Insight

Aug 15, 2025, 06:24

Harpreet Singh: New Era for ADCs in HER-2 + Metastatic Breast Cancer

Science

Aug 15, 2025, 06:18

Ramy Sedhom Shares Study on Inpatient Immunotherapy Outcomes

Science

Aug 15, 2025, 06:11

Miguel Bronchud: Can Use of Aprepitant During Chemotherapy Improve TNBC Outcomes?

Voices

Aug 15, 2025, 06:04

Lung Cancer in Africa: Gaps and Role of a Community of Practice - Move Against Cancer Africa

Voices

Aug 15, 2025, 05:56

Megan Burger: Huge Day for Cancer Care

Science

Aug 15, 2025, 05:47

Gerry Hanna Highlights a Study on Tumor Control and Immune Activation with Palliative Irradiation and ATR Inhibition

Blog Posts

OncoDaily

Blog Posts

Vincent Rajkumar: Reflecting on Top Cited IMWG Papers and the Legacy of Velcade in Myeloma

“As I head to the 16th Annual IMWG summit, I see that 2 of my Top 3 most cited papers are IMWG work. Thanks to my wonderful colleagues. 3 is the SUMMIT trial that led to the first approval of Velcade for myeloma 22 years ago.”